Skip to main content
. 2022 Oct 2;28(12):2298–2307. doi: 10.1111/cns.13978

FIGURE 1.

FIGURE 1

Distribution of the modified Rankin Scale (mRS) at 90 days of the 3‐n‐butylphthalide (NBP) group and the non‐NBP group. The distribution of the mRS score of primary outcomes and mortality in both groups among all patients treated with endovascular treatment are presented in (A). The distribution of the mRS score of primary outcomes and mortality in the propensity score matching data set are presented in (B).